Accessibility Tools

Immunotherapy is not only significantly less effective in liver cancer patients who previously had a liver disease called non-alcoholic steatohepatitis (NASH), but actually appears to fuel tumor growth, according to a Mount Sinai study published in Nature in March.

Read More

Source: Medical Xpress

  • The University of Texas Health Science Center at Houston
  • Baylor College of Medicine
  • Baylor University
  • Houston Methodist, Houston
  • American College of Gastroenterology